1008 GMT - GSK has been among the most mentioned companies across news items over the past four hours, according to Factiva data. Shares of the British pharmaceutical giant rose 0.9% after it said it agreed on a deal valued at 2.5 billion pounds ($3.06 billion) with Chongqing Zhifei Biological Products for the exclusive distribution of its shingles vaccine in China. The three-year deal will start from Jan. 1 and has the option to be further extended. Dow Jones & Co. owns Factiva. (michael.susin@wsj.com)


(END) Dow Jones Newswires

10-09-23 0623ET